_professor-mark-caulfield-co-director-of-the-william-harvey-research-institute-talks-about-pcsk9-and-fourier.jpg "Professor Mark Caulfield, Co-Director of the William Harvey Research Institute talks about PCSK9 and FOURIER from pcsk Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 2 min 29 sec
✓ Published: 19-Mar-2017
✓ Published: 19-Mar-2017
Description:
Prof. Mark Caulfield talks about the FOURIER study in which patients at the William Harvey Clinical Research Centre have been involved. Some of their personal stories are also available on this site.nThis video was produced for the announcement of the results of the FOURIER study, funded by Amgen, in March 2017.nProduction for TrialsConnect was by Greenacre Communications – a London-based video production company specialising in health-care issues and started by John, a former patient involved
Prof. Mark Caulfield talks about the FOURIER study in which patients at the William Harvey Clinical Research Centre have been involved. Some of their personal stories are also available on this site.nThis video was produced for the announcement of the results of the FOURIER study, funded by Amgen, in March 2017.nProduction for TrialsConnect was by Greenacre Communications – a London-based video production company specialising in health-care issues and started by John, a former patient involved
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_pcsk9-po-ozw.webp "PCSK9 po OZW from pcsk")
_trial-design-of-pcsk9-inhibitor-evolocumab-in-pediatric-patients-with-heterozygous-familial-hypercholesterolemia.webp "Trial design of PCSK9-inhibitor, evolocumab, in pediatric patients with heterozygous familial hypercholesterolemia from pcsk")
⏲ 2 min 26 sec ✓ 18-Jun-2018
_pcsk9-i-cz.webp "PCSK9 - I część from pcsk")
_isu-168-pcsk9-de.webp "ISU 168 PCSK9 DE from pcsk")
_ray-kausik-ada-2017-pt-7-pcsk9-inhibitor-side-effects.webp "Ray Kausik ADA 2017 Pt.7 PCSK9 Inhibitor Side Effects from pcsk")
_isu-168-pcsk9-fr.webp "ISU 168 PCSK9 FR from pcsk")
_ray-kausik-ada-2017-pt-1-pcsk9-inhibitor-treatment-for-diabetes.webp "Ray Kausik ADA 2017 Pt.1 PCSK9 Inhibitor Treatment For Diabetes from pcsk")
_ray-kausik-ada-2017-pt-4-pcsk9-and-sglt2-combination-therapy.webp "Ray Kausik ADA 2017 Pt.4 PCSK9 And SGLT2 Combination Therapy from pcsk")
_pcsk9-po-ozw.jpg)
_trial-design-of-pcsk9-inhibitor-evolocumab-in-pediatric-patients-with-heterozygous-familial-hypercholesterolemia.jpg)
_pcsk9-i-cz.jpg)
_isu-168-pcsk9-de.jpg)
_ray-kausik-ada-2017-pt-7-pcsk9-inhibitor-side-effects.jpg)
_isu-168-pcsk9-fr.jpg)
_ray-kausik-ada-2017-pt-1-pcsk9-inhibitor-treatment-for-diabetes.jpg)
_ray-kausik-ada-2017-pt-4-pcsk9-and-sglt2-combination-therapy.jpg)
![[+]](/images/menu.gif){kind=small}